MSC Overview

Financial Results Announcement: Studio City International Holdings Limited will release its unaudited financial results for Q3 2025 on November 6, 2025.

Forward-Looking Statements: The press release includes forward-looking statements that involve risks and uncertainties, which may cause actual results to differ from expectations.

Company Overview: Studio City is a major integrated resort in Cotai, Macau, and is majority owned by Melco Resorts & Entertainment Limited.

Contact Information: The press release provides contact details for media and investor inquiries, including names, titles, and email addresses.

Market Overview: U.S. stocks mostly declined, with the Nasdaq Composite dropping over 200 points on Wednesday.

TJX Companies Performance: TJX shares surged 6.4% to $141.69 after reporting quarterly earnings of $1.10 per share, exceeding estimates, and raising its 2026 EPS guidance.

Notable Stock Gains: Several companies saw significant stock increases, including Guess?, Inc. (+26%), Rocket Pharmaceuticals, Inc. (+19.6%), and Aspen Insurance Holdings Limited (+15.6%).

Additional Stock Movements: Other notable gainers included loanDepot, Inc. (+8%), Almonty Industries Inc. (+8%), and Zepp Health Corporation (+6.5%).

Macau Gaming Revenue Surge: Macau's gross gaming revenue increased by 19% year-over-year in May, reaching 22.1 billion patacas ($2.74 billion), surpassing analyst expectations and marking the highest figure since the pandemic.

Impact of New Developments: The rise in revenue is attributed to new premium gaming tables, VIP suites, high-profile concerts, and a rebound in international visitation, with forecasts for future growth potentially being revised due to this strong performance.

Financial Performance: Studio City International Holdings Limited reported a total operating revenue of US$190.1 million for Q2 2025, an increase from US$161.5 million in Q2 2024, driven by improved mass market operations and higher non-gaming revenues. The company also recorded an operating income of US$23.1 million, up from US$3.0 million the previous year.

Net Loss and Adjusted EBITDA: Despite the revenue growth, Studio City experienced a net loss of US$3.7 million in Q2 2025, significantly reduced from a loss of US$33.4 million in Q2 2024. The Adjusted EBITDA rose to US$76.4 million, compared to US$54.2 million in the same quarter last year, reflecting better operational performance.

Stock Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining over 250 points, while several companies like Mesoblast Limited and Atai Life Sciences saw significant share price increases after positive announcements.

Notable Stock Gains: Other notable gainers included McEwen Inc., Bloomin’ Brands, and Melco Resorts, with shares rising between 9% to 30% due to various factors such as FDA alignment and stock upgrades.